BMAC therapy is an advanced regenerative medicine procedure that uses a patient’s own bone marrow aspirate concentrate to treat damage to joints, cartilage, ligaments, and tendons. The therapy does not involve foreign substances or synthetic medications; it utilizes only the patient’s own biological material.
The procedure is widely used in orthopedics to reduce pain, promote tissue repair, and accelerate recovery after injuries or chronic musculoskeletal conditions.
Injections of bone marrow aspirate concentrate activate the body’s natural regenerative mechanisms. The concentrate contains:
Within the joint, the primary therapeutic effect is immunomodulation, reduction of inflammation, and improvement of the local microenvironment for tissue regeneration. As a result, pain decreases and joint mobility improves. Growth factors regulate the healing process, while platelets enhance soft tissue repair. This approach provides not only symptomatic relief but also supports functional restoration of the affected area.
BMAC therapy is recommended for injuries, degenerative changes, and overload-related conditions, including:
The best outcomes are typically observed in patients with preserved joint space, moderate degenerative changes, and mild to moderate pain.
BMAC therapy is not recommended in the following cases:
All patients undergo consultation with an orthopedic trauma specialist and essential diagnostic evaluation prior to the procedure.
Under local anesthesia, bone marrow aspiration is performed from the iliac crest. The harvesting process takes approximately 10–15 minutes. The collected material is then processed using centrifugation to obtain bone marrow aspirate concentrate — a fraction enriched with regenerative cells and growth factors.
The prepared concentrate is injected into the affected area under ultrasound guidance. This may include a joint cavity, tendon insertion site, or an area of bone damage. The total duration of the procedure is approximately one hour. Hospitalization is not required.
After the procedure, the patient receives recommendations regarding activity modification, permissible movements, and follow-up scheduling.
Unlike symptomatic injections such as hyaluronic acid or corticosteroids, BMAC (bone marrow aspirate concentrate) therapy aims to stimulate intrinsic tissue repair mechanisms.
Main advantages include:
Clinical studies conducted between 2021 and 2024 report that up to 80% of patients experienced improved joint function and pain reduction within 4–8 weeks after the procedure. Treatment efficacy depends on the baseline condition of the tissues and the cellular concentration of the aspirate.
Mashtaler Ortho & Trauma is a specialized orthopedic clinic that implements modern, evidence-based treatment approaches. The clinic was the first in Western Ukraine to perform meniscus and cartilage transplantation procedures and actively adopts innovative regenerative technologies, including BMAC therapy.
Procedures are performed by experienced orthopedic surgeons. All manipulations are conducted under precise imaging guidance using certified centrifugation systems.
BMAC injection is a validated method for managing chronic orthopedic conditions and musculoskeletal injuries. At Mashtaler Ortho & Trauma, the technique is performed in accordance with international standards and approved clinical protocols.
The cost of treatment depends on the number of injections required and the potential need for additional procedures. Pricing is determined by the type of pathology and the severity of joint damage.
For detailed pricing information, please schedule a consultation by phone or via the website contact form.
19700 UAH
Intraoperative administration of bone marrow aspirate concentrate (IUD)
24660 UAH
Introduction of Bone Marrow Aspirate Concentrate (IUAS)